News
Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...
11d
Axios on MSNSally Susman departs Pfizer after 18 yearsPfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...
Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...
Pfizer's chief corporate affairs officer, Sally Susman, recounts how the company managed the massive communications challenge that came with Covid-19 and the race to produce an effective vaccine ...
Executive Vice President and Chief Corporate Affairs Officer, Sally Susman, is leaving after serving the company for 18 long ...
Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights from her newly released book, Breaking Through, to help leaders based on her expertise and ...
Susman described the moment when Pfizer’s top brass, huddled in a small Connecticut office, learned the vaccine worked. “We had over 44,000 people in our clinical trials,” she said.
According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...
Pfizer’s executive vice president and chief corporate affairs officer joins "Morning Joe" co-host Mika Brzezinski on her podcast, "Mika Straight Up," to share lessons about communicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results